Neuropilin-1 Antibody (446921) [DyLight 488]
Novus Biologicals, part of Bio-Techne | Catalog # FAB3870K
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
DyLight 488 (Excitation = 493 nm, Emission = 518 nm)
Antibody Source
Recombinant Monoclonal Mouse IgG2A Clone # 446921
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human Neuropilin-1
Phe22-Lys644
Accession # NP_001019799
Phe22-Lys644
Accession # NP_001019799
Specificity
Detects human Neuropilin-1 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for Neuropilin-1 Antibody (446921) [DyLight 488]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Neuropilin-1
Alternate Names
BDCA-4, CD304, Neuropilin1, NRP1
Gene Symbol
NRP1
Additional Neuropilin-1 Products
Product Documents for Neuropilin-1 Antibody (446921) [DyLight 488]
Product Specific Notices for Neuropilin-1 Antibody (446921) [DyLight 488]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...